The cost-effectiveness of neoadjuvant chemotherapy in women with locally advanced breast cancer: Adriamycin and cyclophosphamide in comparison with paclitaxel and gemcitabine

BACKGROUND: A decision analysis model was developed to assess the cost-effectiveness of adriamycin and cyclophosphamide (AC) in comparison with paclitaxel and gemcitabine (PG) in women with advanced breast cancer in Iran. MATERIALS AND METHODS: This is a cost-effectiveness analysis performed as a cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Javan-Noughabi, Javad, Rezapour, Aziz, Kassani, Aziz, Hatam, Nahid, Ahmadloo, Niloofar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040151/
https://www.ncbi.nlm.nih.gov/pubmed/30057641
http://dx.doi.org/10.4103/jrms.JRMS_644_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040151/
https://www.ncbi.nlm.nih.gov/pubmed/30057641
http://dx.doi.org/10.4103/jrms.JRMS_644_17

Ejemplares similares